Marty Chilberg
Long only, special situations, research analyst, healthcare

Sequenom: Disruptive Innovation Is Driving Investment In NIPT

Sequenom, Inc (NASDAQ:SQNM) summarizes their mission as improving healthcare through revolutionary genetic analysis solutions. They operate in two business segments: Diagnostic Services and Genetic Analysis. Driving my investment thesis in Sequenom is the disruptive innovation occurring in genomic personalized medicine, which is revolutionizing the healthcare industry at a breathtaking pace. Nowhere is this more visible than in the nascent Noninvasive Prenatal Testing ("NIPT") market, in which Sequenom and a few other companies are quite literally changing prenatal care at an unprecedented rate. That these fundamental shifts are occurring so rapidly has compounded existing investor uncertainty caused by a lack of financial visibility. It is my contention that these clouds are beginning to dissipate, revealing a...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details